Company intelligence / Profile preview

iSage

Ownership: Private
Development stage: Other

Overview

iSage provides a digital platform that allows physicians to select from multiple clinically validated basal insulin algorithms and tailor them to individual patient needs. The tool is designed to optimize and personalize the initiation and adjustment of basal insulin therapy in patients with type 2 diabetes. No traditional clinical trial results are reported since it is a software solution rather than a pharmaceutical product[1].

Therapeutic areas: Endocrinology
Modalities: Non-pharmacological therapyDigital therapeutic
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on iSage.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iSage.

Explore the full profile